Last reviewed · How we verify

AlloDerm

Stephen E. Feinberg · FDA-approved active Biologic

AlloDerm is a processed human cadaveric dermal allograft that provides a scaffold for tissue regeneration and wound healing.

AlloDerm is a processed human cadaveric dermal allograft that provides a scaffold for tissue regeneration and wound healing. Used for Soft tissue augmentation and reconstruction, Burn wound coverage, Chronic wound healing.

At a glance

Generic nameAlloDerm
Also known asdonated allograft human dermis, regenerative tissue matrix, AlloDerm SELECT™ RTM,biohorizons
SponsorStephen E. Feinberg
Drug classAcellular dermal matrix allograft
ModalityBiologic
Therapeutic areaRegenerative Medicine / Wound Care
PhaseFDA-approved

Mechanism of action

AlloDerm is an acellular dermal matrix derived from donated human skin that has been processed to remove cellular components while preserving the extracellular matrix structure. When placed in a wound or surgical site, it serves as a biological scaffold that promotes neovascularization, fibroblast infiltration, and integration with host tissue, facilitating natural tissue regeneration and repair.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results